|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/00 | (2006.01) |
| A61K 31/496 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2694043 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12719460.3 |
| Date of filing the European patent application | 2012-04-04 | |
| (97) | Date of publication of the European application | 2014-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-01 |
| (46) | Date of publication of the claims translation | 2018-02-12 |
| (86) | Number | PCT/JP2012/059825 |
| Date | 2012-04-04 |
| (87) | Number | WO 2012/137971 |
| Date | 2012-10-11 |
| (30) | Number | Date | Country code |
| 201161471911 P | 2011-04-05 | US | |
| 201161580540 P | 2011-12-27 | US |
| (72) |
HIROSE, Tsuyoshi, JP
MAEDA, Kenji, JP
KIKUCHI, Tetsuro, JP
TODA, Masafumi, JP
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
2-9, Kanda-Tsukasamachi Chiyoda-ku, Tokyo 101-8535,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Deriniai, apimantys brekspiprazolą arba jo druską ir antrą vaistą, skirti panaudoti CNS sutrikimo gydymui |
| COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER |
| Payment date | Validity (years) | Amount | |
| 2019-03-21 | 8 | 185.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2019-11-15 |